Evidence map›Paper›PMID 37938408›Full record

ArticleStem cell reviews and reports2024

Differentiation of Neurons, Astrocytes, Oligodendrocytes and Microglia From Human Induced Pluripotent Stem Cells to Form Neural Tissue-On-Chip: A Neuroinflammation Model to Evaluate the Therapeutic Potential of Extracellular Vesicles Derived from Mesenchymal Stem Cells.

Pelin Saglam-Metiner, Elif Duran, Leila Sabour-Takanlou, Cigir Biray-Avci, Ozlem Yesil-Celiktas

Abstract read
PubMed Publisher
In one paragraph

Article in Stem cell reviews and reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
2.5field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 16 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Bridging the Gap Between Static Histology and Dynamic Organ-on-a-Chip Models.Pathophysiology : the official journal of the International Society for Pathophysiology · 2026
    Review
  6. Review
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

Pelin Saglam-MetinerDepartment of Bioengineering, Faculty of Engineering, Ege University, Izmir, Turkey.ORCID 0000-0002-5726-1928
Elif DuranDepartment of Bioengineering, Faculty of Engineering, Ege University, Izmir, Turkey.ORCID 0000-0002-8554-2604
Leila Sabour-TakanlouDepartment of Medical Biology, Faculty of Medicine, Ege University, Izmir, Turkey.ORCID 0000-0002-6361-7150
Cigir Biray-AvciDepartment of Medical Biology, Faculty of Medicine, Ege University, Izmir, Turkey.ORCID 0000-0001-8251-4520
Ozlem Yesil-CeliktasDepartment of Bioengineering, Faculty of Engineering, Ege University, Izmir, Turkey. ozlem.yesil.celiktas@ege.edu.tr.ORCID 0000-0003-4509-2212
Ege University · TRUtrecht University · NL

Funding

Türkiye Bilimsel ve Teknolojik Araştırma Kurumu 119M578
6 · The paper itself

Abstract

Advances in stem cell (SC) technology allow the generation of cellular models that recapitulate the histological, molecular and physiological properties of humanized in vitro three dimensional (3D) models, as well as production of cell-derived therapeutics such as extracellular vesicles (EVs). Improvements in organ-on-chip platforms and human induced pluripotent stem cells (hiPSCs) derived neural/glial cells provide unprecedented systems for studying 3D personalized neural tissue modeling with easy setup and fast output. Here, we highlight the key points in differentiation procedures for neurons, astrocytes, oligodendrocytes and microglia from single origin hiPSCs. Additionally, we present a well-defined humanized neural tissue-on-chip model composed of differentiated cells with the same genetic backgrounds, as well as the therapeutic potential of bone marrow mesenchymal stem cells (BMSCs)-derived extracellular vesicles to propose a novel treatment for neuroinflammation derived diseases. Around 100 nm CD9 + EVs promote a more anti-inflammatory and pro-remodeling of cell-cell interaction cytokine responses on tumor necrosis factor-α (TNF-α) induced neuroinflammation in neural tissue-on-chip model which is ideal for modeling authentic neural-glial patho-physiology.

Indexed as

Extracellular VesiclesInduced Pluripotent Stem CellsMesenchymal Stem CellsAstrocytesHumansMicrogliaNeuroinflammatory DiseasesNeuronsOligodendrogliaDifferentiationExtracellular vesiclesInduced pluripotent stem cellsNeuroinflammationOrgan-on-a-chip

Identifiers

PMID37938408
OpenAlexW4388498714

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.